These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 31138418)
1. Hepatitis C virus infection and new treatment strategies. García Deltoro M; Ricart Olmos C Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():15-19. PubMed ID: 31138418 [TBL] [Abstract][Full Text] [Related]
2. Analysis of the results of the SEIMC External Quality Control Programme for HIV-1, HCV, and HBV viral loads. Year 2016. Orta Mira N; Del Remedio Guna Serrano M; Carlos Latorre Martínez J; Ruiz de Gopegui E; Rosario Ovies M; Poveda M; Gimeno Cardona YC Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():9-14. PubMed ID: 31138424 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the results of the SEIMC External Quality Control Program. Year 2016. Ruiz de Gopegui Bordes E; Orta Mira N; Del Remedio Guna Serrano M; Valero García I; Rosario Ovies M; Poveda M; Gimeno Cardona C Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():1-8. PubMed ID: 31138417 [TBL] [Abstract][Full Text] [Related]
5. Serology in the xxi century: is it still of interest? García Coca M; Fernández Roblas R; Gadea Gironés I Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():40-46. PubMed ID: 31138422 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of soil-transmitted helminth infections. An unsolved problemin the omics era. Fernández-Rivas G; Rivaya B; Romaní N; Hao Wang J; Alcaide M; Matas L Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():20-25. PubMed ID: 31138419 [TBL] [Abstract][Full Text] [Related]
7. Optimisation in the multidisciplinary approach to patients with hepatitis C in the era of direct-acting antivirals. Calleja JL; Bermúdez Á; Camacho Á; Cárdenas F; Fernández S; de Juan J; Jorquera F; Linares M; Rodríguez MÁ; Romero M; Ruiz JJ; José Sánchez M; de la Vega J Gastroenterol Hepatol; 2019 Sep; 42 Suppl 1():8-13. PubMed ID: 32560771 [TBL] [Abstract][Full Text] [Related]
9. Quality of life in patients with hepatitis C. Importance of treatment. Mallolas J; Ahumada A; Ampuero J; Blanco JR; Hidalgo Á; Londoño MC; Molina E; Ruiz S Gastroenterol Hepatol; 2019 Sep; 42 Suppl 1():20-25. PubMed ID: 32560769 [TBL] [Abstract][Full Text] [Related]
10. Updating of in vitro antifungal susceptibility tests. Castro Méndez C; García Sánchez E; Martín-Mazuelos E Enferm Infecc Microbiol Clin (Engl Ed); 2019 May; 37 Suppl 1():32-39. PubMed ID: 31138421 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-positive donors in HCV-negative recipients in liver transplantation: Is it possible in Mexico? Torres-Díaz JA; Jasso-Baltazar EA; Toapanta-Yanchapaxi L; Aguirre-Valadez J; Martínez-Matínez L; Sánchez-Cedillo A; Aguirre-Villarreal D; García-Juárez I Rev Gastroenterol Mex (Engl Ed); 2023; 88(4):392-403. PubMed ID: 38097433 [TBL] [Abstract][Full Text] [Related]
12. Executive summary: Consensus document of GEHEP of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), along with SOCIDROGALCOHOL, SEPD and SOMAPA on hepatitis C virus infection management in drug users. Pineda JA; Climent B; García F; García Deltoro M; Granados R; Gómez F; Macías J; Mena Á; Merchante N; Ochoa E; Roncero C; Ruiz JJ; Téllez F; Morano L Enferm Infecc Microbiol Clin (Engl Ed); 2020 Mar; 38(3):127-131. PubMed ID: 30415884 [TBL] [Abstract][Full Text] [Related]
13. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review. Gutiérrez-Rojas L; de la Gándara Martín JJ; García Buey L; Uriz Otano JI; Mena Á; Roncero C Gastroenterol Hepatol; 2023 May; 46(5):382-396. PubMed ID: 35718017 [TBL] [Abstract][Full Text] [Related]
14. The impact of the revolution in hepatitis C treatment on hepatocellular carcinoma. Wirth TC; Manns MP Ann Oncol; 2016 Aug; 27(8):1467-74. PubMed ID: 27226385 [TBL] [Abstract][Full Text] [Related]
15. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714 [TBL] [Abstract][Full Text] [Related]
16. Importance of adherence to treatment with direct-acting antivirals in hepatitis C. Monte-Boquet E; Verdugo RM; Navarro H; Quer JC; Ventayol P Gastroenterol Hepatol; 2019 Sep; 42 Suppl 1():14-19. PubMed ID: 32560768 [TBL] [Abstract][Full Text] [Related]
17. Economic impact of health resource optimisation in the approach to patients with hepatitis C. Turnes J; García F; Diago M; Andrade RJ; Díaz P; Rubio-Rodríguez D; Rubio-Terrés C Gastroenterol Hepatol; 2019 Sep; 42 Suppl 1():26-33. PubMed ID: 32560770 [TBL] [Abstract][Full Text] [Related]
18. New Therapies for Hepatitis C Virus. Polenakovik H Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(2):119-32. PubMed ID: 27442378 [TBL] [Abstract][Full Text] [Related]
19. Development of novel treatments for hepatitis C. Webster DP; Klenerman P; Collier J; Jeffery KJ Lancet Infect Dis; 2009 Feb; 9(2):108-17. PubMed ID: 19179226 [TBL] [Abstract][Full Text] [Related]
20. Direct antiviral agents (DAAs) - A new age in the treatment of hepatitis C virus infection. Spengler U Pharmacol Ther; 2018 Mar; 183():118-126. PubMed ID: 29024739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]